首页> 美国卫生研究院文献>Pediatric Rheumatology Online Journal >Pharmacovigilance in juvenile idiopathic arthritis patients (Pharmachild) treated with biologic agents and/or methotrexate. Consolidated baseline characteristics from Pharmachild and other national registries

【2h】

Pharmacovigilance in juvenile idiopathic arthritis patients (Pharmachild) treated with biologic agents and/or methotrexate. Consolidated baseline characteristics from Pharmachild and other national registries

机译：用生物制剂和/或甲氨蝶呤治疗的幼年特发性关节炎患者（Pharmachild）的药物警戒。 Pharmachild和其他国家注册中心的综合基线特征

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

期刊名称 Pediatric Rheumatology Online Journal
作者
Joost Swart; Alessandro Consolaro; Gerd Horneff; Kimme L Hyrich; Francesca Bovis; Jose Melo-Gomes; Ekaterina Alexeeva; Stefano Lanni; Gerd Ganser; Violeta Panaviene; Jordi Anton; Ivan Foeldvari; Valda Stanevicha; Susan Nielsen; Ralf Trauzeddel; Constantin Ailioaie; Pierre Quartier; Toni Hospach; Gordana Susic; Maria Trachana; Frank Weller-Heinemann; Alberto Martini; Nico Wulffraat; Nicolino Ruperto;
展开▼
作者单位

展开▼
年(卷),期 2014(12),Suppl 1
年度 2014
页码 P7
总页数 2
原文格式 PDF
正文语种
中图分类儿科学;免疫性疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Pharmacovigilance in juvenile idiopathic arthritis patients (Pharmachild) treated with biologic agents and/or methotrexate. Consolidated baseline characteristics from Pharmachild and other national registries [J] . Joost Swart, Alessandro Consolaro, Gerd Horneff, Pediatric rheumatology online journal . 2014,第S1期

机译：用生物制剂和/或甲氨蝶呤治疗的幼年特发性关节炎患者（Pharmachild）的药物警戒。 Pharmachild和其他国家注册中心的综合基线特征
2. Pharmacovigilance in juvenile idiopathic arthritis patients (Pharmachild) treated with biologic agents and/or methotrexate. Consolidated baseline characteristics from Pharmachild and other national registries [J] . Joost Swart, Alessandro Consolaro, Gerd Horneff, Pediatric rheumatology online journal . 2014,第S1期

机译：用生物制剂和/或甲氨蝶呤治疗的幼年特发性关节炎患者（Pharmachild）的药物警戒。 Pharmachild和其他国家注册中心的综合基线特征
3. Opportunistic infections in immunosuppressed patients with juvenile idiopathic arthritis: analysis by the Pharmachild Safety Adjudication Committee [J] . Gabriella Giancane, Joost F. Swart, Elio Castagnola, Arthritis research & therapy. . 2020,第1期

机译：少年特发性关节炎的免疫抑制患者的机会性感染：Pharmachild安全裁决委员会分析
4. Change Point Detection in Knee Acoustic Emissions using the Teager Operator: A Preliminary Study in Patients with Juvenile Idiopathic Arthritis [C] . Beren Semiz, Sinan Hersek, Daniel C. Whittingslow, IEEE EMBS International Conference on Biomedical Health Informatics . 2019

机译：使用Teager操作员检测膝盖声发射中的变化点：对青少年特发性关节炎患者的初步研究
5. Real-world Effectiveness of Biologic Therapies in Children and Adults with Juvenile Idiopathic Arthritis in the United Kingdom [D] . Kearsley-Fleet, Lianne. 2019

机译：英国青少年特发性关节炎儿童和成人生物疗法的现实世界效力
6. Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15000 patients from Pharmachild and national registries [O] . Joost Swart, Gabriella Giancane, Gerd Horneff, 2018

机译：用生物或合成药物治疗的青少年特发性关节炎患者的药物警戒：来自Pharmachild和国家注册机构的15000多例患者的合并数据
7. Pharmacovigilance in juvenile idiopathic arthritis patients (Pharmachild) treated with biologic agents and/or methotrexate. Consolidated baseline characteristics from Pharmachild and other national registries [O] . Joost Swart, Alessandro Consolaro, Gerd Horneff, 2014

机译：用生物制剂和/或甲氨蝶呤治疗的幼年特发性关节炎患者（Pharmachild）的药物警戒。 Pharmachild和其他国家注册中心的综合基线特征

Pharmacovigilance in juvenile idiopathic arthritis patients (Pharmachild) treated with biologic agents and/or methotrexate. Consolidated baseline characteristics from Pharmachild and other national registries

著录项

引文网络

相似文献

相关主题

期刊订阅